BIOSK — Unibios Holdings SA Income Statement
0.000.00%
- €25.20m
- €28.33m
- €12.98m
- 71
- 65
- 64
- 79
Annual income statement for Unibios Holdings SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8.34 | 7.3 | 8.48 | 11.2 | 13 |
Cost of Revenue | |||||
Gross Profit | 3.44 | 2.7 | 3.12 | 4.19 | 4.89 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 7.58 | 6.87 | 7.56 | 9.86 | 9.95 |
Operating Profit | 0.758 | 0.43 | 0.921 | 1.39 | 3.03 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.305 | 0.042 | 0.552 | 0.998 | 2.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.1 | -0.091 | 0.334 | 0.651 | 2.03 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 0.1 | -0.091 | 0.334 | 0.651 | 2.03 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.1 | -0.091 | 0.334 | 0.651 | 2.03 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.006 | -0.005 | 0.021 | 0.042 | 0.118 |
Dividends per Share | |||||
Special Dividends per Share |